summary 1. Studies were performed to investigate the metabolic fate of dipeptides when administered intravenously in rats. Glycyl-leucine, glycylglycine or glycylsarcosine was injected into the jugular vein. The plasma disappearance rate after the peak plasma concentrations was most rapid for glycyl-leucine and least rapid for glycylsarcosine.
1.
Studies were performed to investigate the metabolic fate of dipeptides when administered intravenously in rats. Glycyl-leucine, glycylglycine or glycylsarcosine was injected into the jugular vein. The plasma disappearance rate after the peak plasma concentrations was most rapid for glycyl-leucine and least rapid for glycylsarcosine.
2. During urine collection for 40 min, trace amounts of glycyl-leucine and glycylglycine and leucine injection was 1.6 times that produced after the injection of the corresponding amino acid mixture.
5. Results show that, within the present experimental conditions, the intravenous administration of dipeptides is as effective as that of the corresponding free amino acids in enriching the tissue pools of amino acids. It is suggested that efficient hydrolysis by cellular enzymes prohibits accumulation of intact dipeptides in body tissues.
was detected in the liver, muscle, intestinal mucosa or renal cortex, but Concentrations of glycine or leucine, or both. in these tissues were Introduction increased after each injection. In contrast, glycylsarcosine was recovered in all these tissues with concentrations in the renal cortex being far greater than in any other tissue, but sarcosine was found only in the renal cortex and intestinal mucosa.
4. The changes in plasma concentrations of free amino acids, glucose and glucagon, and tissue concentrations of free amino acids, were Small peptides are quantitatively an important product of protein digestion in the gut lumen of man and rat (Adibi & Mercer, 1973; Chen, Rogers & Harper, 1962) . Recent studies have indicated that there is mucosal uptake of a wide range of dipeptides in the intestine of both man and rat (Adibi, 1976; Matthews, 1975) . Furthermore, after protein meals or installation of peptide in the gut lumen, some dipeptides have similar after the intravenous administration of been shown to appear in plasma (Adibi, 1971b ; glycyl-leucine and an equimolar mixture of free Adibi, Morse, Masilamani & Amin, 1975 ; glycine and leucine. However, the amount of Boullin, Crampton, Heading & Pelling, 1973 ; insulin secreted during the 40 min after glycylPerry, Hansen, Tischler, Bunting & Berry, 1967; Prockop, Keiser & Sjoerdsma, 1962) . In view of these observations, questions regarding the metabolism of circulating dipeptides might be raised. For example, can dipeptides be given intravenously to enrich the body pool of amino acids, or will they be excreted into urine as unusable substrate? The present studies were therefore designed to determine the fate of intravenously administered dipeptides by investigating the dynamics of their disappearance from the blood, their excretion in the urine and their effects on plasma and tissue concentrations of free amino acids in the rat. Amino acids may alter pancreatic secretion of insulin and glucagon and hepatic production of glucose (Exton & Park, 1972) . Insulin, glucagon and glucose may, in turn, change plasma concentrations of amino acids . Because of these metabolic interactions, the plasma concentrations of insulin, glucagon and glucose were investigated in the dipeptide-injected animals. Additional studies were performed to determine whether alterations in free amino acid pools in plasma and tissues, plasma glucose concentrations and insulin and glucagon secretion would differ if the same amino acids were injected in dipeptide or free form.
The dipeptides used were glycylglycine, glycyl-L-leucine and glycylsarcosine. The initial two dipeptides, which have been used extensively as models for studies of intestinal transport in humans in our laboratory (Adibi, 1975) , are representative of dipeptides with relatively slow and rapid rates of hydrolysis respectively by tissue peptide hydrolases (Fogel & Adibi, 1974) . Although the peptide composition of protein hydrolysates is not yet well known, the studies of protein digestion in vivo have shown that both glycine and leucine are abundant in the peptide fraction (Adibi & Mercer, 1973) . Glycylsarcosine, an analogue of glycylglycine, was administered to investigate the plasma disappearance and tissue concentrations of a dipeptide which is resistant to hydrolysis by peptide hydrolases of rat tissue (Smith, 1951) . In a previous study, glycylsarcosine was used as a model substrate for the demonstration of an active transport system for dipeptides in hamster jejunum in ritro (Addison, Burston & Matthews, 1972) .
Preliminary communications pertaining to the above studies have been previously published as abstracts (Adibi, Krzysik. Drash & Peterson, 1974; .
Materials and methods
Male Sprague-Dawley rats, weighing 270-300 g, were lightly annesthetized with ether between 09.00 and 11 .OO hours. Rats had access to food (Purina Laboratory Chow) and water until 1 h before being anaesthetized. The right jugular vein was injected (0.5 pmol/g body weight) with one of the following test solutions: NaCl (150 mmol/l), glycyl-L-leucine (1 50 mmol/l), glycine (1 50 mmol/l) + L-leucine (1 50 mmol/l), glycylglycine (1 50 mmol/l), glycylsarcosine (150 mmol/l) or glycine (300 mmol/l; 1 .O pmol/g body weight). Glycylsarcosine was purchased from Sigma Chemical Co., St Louis, Missouri, U.S.A. The other dipeptides and free amino acids were purchased from Grand Island Biological Co., Grand Island, New York, U.S.A. Solutions were made isotonic with the addition of an appropriate amount of NaCI, and were in,jected over a period of 30 s. Animals to be killed at 10 min or longer after the injection were allowed to awaken, but were anaesthetized with ether again beginning at 2 min before the time for blood collection or tissue removal. Animals to be killed within the first 5 min after the injection were kept under ether anaesthesia and were not allowed to awaken. Just before killing, a midline incision was made in the abdomen of each anaesthetized animal, and the viscera were exposed.
Blood was obtained from the abdominal aorta at 2, 5, 10, 15, 20, 30, 40 and 60 min after the injection. Only one blood collection was made in each rat. In addition to control rats injected with NaCl solution (150 mmol/l; saline), aortic blood was also obtained from rats anaesthetized with ether but which received no injection. Initially, studies were performed to compare the concentrations of free amino acids and dipeptides in whole blood versus plasma. The blood was collected in heparinized test tubes and processed immediately by one or both of the following methods. (a) A portion (1 ml) of 6% sulphosalicylic acid was added to a test tube containing 1 ml of whole blood. The tube was shaken and centrifuged at 500 g for 5 min.
The protein-free supernatant was reserved for analysis. (b) Plasma was separated from the blood cells by centrifugation of whole blood at 500 g for 5 rnin; plasma was then deproteinized with addition of an appropriate volume of 6% sulphosalicylic acid (0.5-12.0 ml/l ml of plasma) and centrifuged at 500 g for 5 rnin.
Under basal conditions, except for glycine, there were no significant differences between the concentrations of free amino acids in plasma and in whole blood. The concentration (mean + SEM in six rats) of free glycine was slightly greater in whole blood (396 + 9 pmolll) than in plasma (341 + 1 pmolll). After injection of glycyl-leucine, as a whole, the concentrations of free amino acids and dipeptide tended to be higher in plasma. After the injection of glycylglycine, the concentrations (mean +SEM in six rats) of free amino acids and dipeptide, except that of glycine, were similar in whole blood and plasma. The concentration of glycine, after glycylglycine injection, was significantly greater in plasma (1342 k 52 pmol/l) than in whole blood (1158 +49 pmol/l). Therefore, plasma rather than whole blood was chosen for our studies because the concentrations OT free glycine and leucine, after dipeptide injections, in whole blood may underestimate their amounts in circulation.
Glucose concentration in plasma was determined by the glucose oxidase method (Pileggi & Szustkiewicz, 1974) . Insulin was measured by the radioimmunoassay method of Yalow & Berson (1960) , as modified by Herbert, Lau, Gottlieb & Bleicher (1965) . Rat insulin standards were kindly provided by Dr Mary Root of Eli Lilly Co., Indianapolis, Indiana, U.S.A. Glucagon was measured by radioimmunoassay with antiserum K30 according to the method of Aguilar-Parata, Eisentraut & Unger (1969) .
Gastrocnemius muscle, liver, kidney and 15 cm of small intestine just distal to the ligament of Treitz were obtained at 5 or 30 min after the injection of each of the above test solutions. These tissues were also obtained in rats which were anaesthetized but not injected. In order to minimize freezing time, pieces of gastrocnemius muscle and liver were immediately freezeclamped, with flattened modified pliers which had been frozen in liquid nitrogen. After removal of the capsule, kidney cortex slices (about 0.5 mm) were cut with a Stadie-Riggs microtome and dropped into liquid nitrogen. The intestinal segment was cut open lengthwise on an ice-cold glass plate, and the mucosa was scraped with a glass slide and dropped into liquid nitrogen. Deproteinized supernatant from each tissue was obtained by the methods previously described (Adibi, 1971a) .
The concentrations of free amino acids and dipeptides in plasma and tissue supernatant were investigated by an ion-exchange chromatography technique using the Beckman model 120C Amino Acid Analyzer (Adibi, 1971b) . The samples were placed on top of a cationicexchange column (UR-30 resin, Beckman Instruments Inc., Palo Alto, California, U.S.A.). The column was then eluted with sodium citrate buffer (200 mmol/l), pH 3.20, for 200 rnin and then with sodium citrate buffer, pH 4.26, for another 180 min. The starting temperature was 30"C, but after 70 min it was changed to 62°C. A typical chromatogram of elution pattern of plasma amino acids and dipeptides is shown in Fig. 1 . In our laboratory the concentration of amino acids or dipeptides is accurately measured to 0.01 pmol/ml, and fairly well estimated to 0.001 pmol/ml. It has become common practice to present the concentrations of amino acids in plasma as pmol/l. As a result, the last whole number of any plasma concentration value, given in the text, is an estimate. Amino acid concentrations in tissues could be expressed either per tissue weight or as intracellular concentration. Using previously published methods (Adibi, Morse & Mirsky, 1976) , we calculated the intracellular concentration of the dipeptides. The pattern of dipeptide accumulation in tissues was the same regardless of the method of expression used. Since the expression of the intracellular concentration did not appear to offer any advantage and required several assumptions (Nallathambi, Goorin & Adibi, 1972) , we chose to present the tissue concentration per tissue weight.
Urine collection was made in rats injected with either saline, glycylglycine, glycyl-leucine or glycylsarcosine test solutions and kept under ether for the entire 40 min interval. After 40 min, the bladder was clamped off and removed.
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Urine was collected into a graduated centrifuge tube kept in ice. The bladder was washed twice with water, and the water rinses were added to the centrifuge tube. There was no urination while rats were kept under ether. The amino acid and peptide analysis of urine was carried out as described above. The results are given as mean values f l SEM. Student's t-test was used for the statistical analysis of results. (Fig. 2) Before intravenous injection, no glycylglycine, glycyl-leucine or glycylsarcosine was detected in the plasma. Two minutes after the injection the plasma values (mean f SEM) of glycylglycine, glycyl-leucine and glycylsarcosine were 1059 59,784 f 153 and 2516 k 197 pmol/l respectively.
Results
Dynamics of dipeptide disappearance from plasma
After this interval, the concentrations of all three dipeptides progressively decreased until FIG. 3. Plasma concentrations ( m e a n f s~~, six rats) of free glycine before (0: paired anaesthetized rats) and at intervals after intravenous injection of glycyl-leucine (----) , equimolar mixture of glycine and leucine (-*-) or saline (-) .
The differences in glycine concentrations after injection of glycyl-leucine and the corresponding free amino acid mixture were not statistically significant.
by 40 rnin neither glycyl-leucine nor glycylglycine was any longer detectable in plasma. In contrast, glycylsarcosine was detectable even 60 min after the injection (81 f 17 pmolll). There was a more rapid clearance of glycyl-leucine than glycylglycine. This was apparent from a comparison of plasma values at 5 and 10 min after the injection. The plasma disappearance of glycylsarcosine was much less rapid than that of glycylglycine. The concentration of glycylsarcosine in the plasma at each interval was significantly greater (P < 0.01) than that of glycylglycine.
Free amino acid Concentrations in plasma
The plasma concentrations of free glycine and free leucine before and after the injection of glycyl-leucine are shown in Fig. 3 and Fig. 4 . As was the case with dipeptide, their greatest increases over base-line concentrations were detected at 2 rnin after the injection (1113 and 942 pmol/l for free glycine and free leucine respectively). After 2 min, the concentrations of both free glycine and free leucine progressively decreased and approached the base line by 40 min. Fig. 3 and Fig. 4 also show plasma concentrations of free glycine and free leucine after the injection of an equivalent mixture of free glycine and free leucine. At each examined interval, there was no significant difference between the values for either free glycine or free leucine whether the dipeptide or the corresponding free amino acid mixture was injected.
Results for the plasma free glycine concentrations before and after the injection of either glycylglycine or an equivalent amount of free glycine are summarized in Fig. 5 . The largest increase in glycine concentration after either solution was found at 2 min after the injection. This increase, however, was greater after free glycine than glycylglycine (301 1 ,umol/l vs. 2283 pmol/l, P < 0.01). After 2 rnin there were gradual decreases in plasma free glycine in glycylglycineinjected rats, and there was a sharp fall in glycine-injected rats. Owing to this sharp fall, the plasma free glycine values at 5 and 10 rnin after the injection were significantly lower (P < 0.01) in free glycine-injected rats than in glycyl- concentrations of both glycine and leucine remained fairly stable during 40 min after saline injection. Concentrations of glycine at all intervals (2-40 min) after saline injection were not significantly different from those of noninjected rats. However, the reductions in plasma concentrations of leucine at 10, 20 and 40 min were statistically significant (P <0.01). At none of the intervals examined was sarcosine detected in plasma; however, there were slight increases in plasma concentration of glycine after glycylsarcosine injection (Fig. 5) . Plasma concentrations of eight individual free amino acids (serine, threonine, alanine, valine, methionine, isoleucine, phenylalanine and tyrosine) during 40 min after injection of saline, glycyl-leucine, glycylglycine and the corresponding free amino acid mixtures were investigated (data not shown). After saline injection, concentrations of serine, threonine and methionine were not significantly changed at any interval, but there were occasional significant decreases in concentrations of alanine, valine, phenylalanine, isoleucine and tyrosine at some intervals after 10 min. The patterns of changes in concentrations of these eight amino acids in dipeptide-injected and free amino acid-injected rats were essentially similar to one another and were characterized by initial (first 2-5 min) increases in the concentrations of most amino acids followed by decreases for all eight free amino acids. In general, plasma concentrations of amino acids in amino acid and dipeptide-injected rats were lower than those of saline-injected rats.
Plasma concentration of glucose, insirlin and glucagon in response to injections
Results for plasma concentrations of glucose, insulin and glucagon before and after saline injection are summarized in Fig. 6 . Glucose concentration became significantly elevated during the initial 20 min after saline injection, but returned to near the basal value at subsequent intervals. Although the mean insulin concentration at the 5 min interval appeared to be increased, the increase was not statistically significant. Except for modest decreases at 2 and 10 min intervals, the changes in plasma glucagon (-) or glycine plus leucine (---- concentrations in response to saline injection were not significant.
FIG. 7. Plasma concentration (meanf SEM, five rats) of insulin, glucose and glucagon before (0) and at intervals after intravenous injection of either glycyl-leucine
In Fig. 7 , the effects of glycyl-leucine and a corresponding mixture of free amino acids on plasma concentrations of glucose, insulin and glucagon are compared. The injection of both glycyl-leucine and the mixture of free glycine and leucine caused elevation of plasma glucose concentrations as compared with the basal value (P<O.Ol). The pattern of increase in plasma glucose concentration was essentially similar in both groups of rats (Fig. 7) and did not significantly differ from that of saline-injected rats (Fig. 6 ). Both glycyl-leucine and the mixture of free glycine and leucine stimulated glucagon secretion. The plasma glucagon elevations at 20 and 30 rnin after both injections (Fig. 7) were significantly greater (P between <0.05 and < 0.01) in amino acid-and dipeptide-injected rats than in saline-injected rats (Fig. 6) . There was no significant difference between glucagon concentrations in plasma of amino acid-and dipeptide-injected rats. Glycyl-leucine and the mixture of free glycine and free leucine also stimulated insulin secretion. The insulin values after amino acid and dipeptide injections compared with salineinjected rats were significantly greater during the initial 15 and 20 rnin intervals respectively. Insulin values at several intervals were greater after dipeptide than amino acid injection (the differences were significant at 20 and 30 min). The amount of insulin secretion was estimated by planimetric integration of the area under the curves describing insulin concentration as a function of time after glycyl-leucine and the corresponding amino acid mixture (Fig. 7) . The amount of insulin secreted in 40 min after glycyl-leucine injection was 1.6 times that after the mixture of glycine and leucine. In Fig. 8 , the effects of glycylglycine and the corresponding free glycine solution on plasma concentrations of glucose and insulin are compared. The insulin values after dipeptide injection were not significantly different from those after glycine injection at any interval examined. The glucose concentrations after glycine injection were consistently higher than those after glycylglycine, with significant differences after 2, 10, 30 and 40 min. 
Urinary excretion of free amino acids and dipeptides
During the 40 min after the injection of glycyl-leucine or glycylglycine, trace amounts of dipeptide and constituent amino acids were excreted in urine ( Table 1) . The amounts of the other free amino acids excreted were not significantly different after the dipeptide or saline injections. In contrast to glycyl-leucine and glycylglycine, there was a large urinary excretion of glycylsarcosine; 13 % of the injected load was lost in the urine as glycylsarcosine during 40 min of urine collection.
Concentrations of amino acids and peptides in tissues
The liver, skeletal muscle and the kidney concentrations of free glycine and free leucine before and at intervals after the injection of saline or glycyl-leucine or the corresponding free amino acid mixtures are shown in Fig. 9 . At 5 min, which corresponded to the time when there was the sharpest decrease in the plasma concentration of glycyl-leucine (Fig. 2) , there were significant increases in concentrations of both free glycine and free leucine in all three tissues. These expansions in pool sizes were similar whether the rats were injected with glycyl-leucine or the corresponding free amino acid mixture. At 30 min after the injection, when the glycyl-leucine had almost disappeared from the plasma and the plasma concentrations of both free glycine and free leucine approached basal values, there were decreases in tissue concentrations of free glycine and free leucine from the preceding elevated values. However, except for glycine in the kidney, the concentrations of both of these amino acids at 30 min were still higher in the tissues of the amino acid-and dipeptide-injected rats than in those of salineinjected rats. The tissue concentrations of either glycine or leucine were not significantly changed after saline injection.
Concentrations of free glycine in the liver, muscle and kidney were markedly increased 5 min after injection of glycylglycine (data not shown). Neither glycyl-leucine nor glycylglycine was detected in the three tissues at either 5 or 30 min after injection of these dipeptides.
Tissue concentrations of glycylsarcosine and sarcosine at 5 and 30 min after the injection of glycylsarcosine are summarized in Fig. 10 . In contrast to glycylglycine and glycyl-leucine, which were not found in tissues, glycylsarcosine was detected in all tissues examined (liver, kidney, muscle, intestinal mucosa). The concentration of glycylsarcosine was always greater in the renal cortex than in the other tissues, or even in plasma. Although sarcosine was not detected in the liver or muscle, the renal cortex and the intestinal mucosa contained sarcosine after the injection of glycylsarcosine. The concentrations of sarcosine in the renal cortex were markedly greater than those of intestinal mucosa. As compared with saline injection, there were no significant changes in glycine concentration in the liver, muscle and intestinal mucosa after the glycylsarcosine injection, but there were significant increases (P <0.01) in glycine concentration in the renal cortex. The renal cortical concentrations (mean + SEM) of glycine before and at 5 and 30 min after the injection were 2.29 k0.32, 7.70 k 0.55 and 5.07 + 0.36 pmol/g respectively.
The concentrations of the same eight free amino acids (serine, threonine, alanine, valine, methionine, isoleucine, tyrosine and phenylalanine) as measured in plasma were also deter-Time hinl FIG. 9. Concentrations (meanf SEM, five rats) of free glycine and free leucine in tissues of rats before and at intervals after injection of glycyl-leucine (-. -), equimolar mixture of free glycine and free leucine (----) or saline (-) . The differences in tissue concentrations of glycine or the differences in tissue concentrations of leucine in the dipeptide compared with amino acid-injected rats were not statistically significant. Concentrations of leucine or glycine in dipeptide-or amino acid-injected rats were significantly greater (* P< 0.01 and **P< 0 0 5 ) than those of the paired saline-injected control rats. mined in the three tissues before and at intervals Discussion after the injection of saline, glycyl-leucine, glycylglycine or the corresponding free amino acid acid mixtures (data not shown). In comparison with marked increases in tissue concentrations of free glycine and free leucine (Fig. 9 ) there were modest decreases or insignificant changes in the concentrations of the eight non-injected free amino acids in the muscle, liver and kidney after injections of the dipeptides or the free amino acid mixtures. Tissue concentrations of these amino acids after saline injection remained either unchanged or slightly decreased.
Mechanisms of disappearance
The present observations establish that dipeptides such as glycyl-leucine or glycylglycine, when introduced directly into the systemic circulation of rats, rapidly disappear from plasma. The following mechanisms might be involved in this phenomenon: (a) excretion of dipeptides into the urine; (b) hydrolysis of dipeptides in the bloodstream; (c) uptake of dipeptides by one or more tissues followed by intracellular hydrolysis; (d) hydrolysis of dipep- FIG. 10 . Concentration (mean& SEM) of glycylsarcosine (solid columns) and sarcosine (hatched columns), 5 min (a, four rats) and 30 min (b, six rats) after the injection of glycylsarcosine, in the renal cortex, intestinal mucosa, liver and gastrocnemius muscle. For comparison with tissue concentrations, the mean plasma concentrations (pmol/ml) of glycylsarcosine at (a) 5 and (b) 30 min after the injection of this dipeptide are also presented. From previously published formulae (Adibi ef ol., 1976) intracellular concentration of glycylsarcosine in the renal cortex was calculated to be over threefold that of plasma at 5 min and to be over fourfold that of plasma at 30 min.
tides on the cell surface of one or more tissues.
Urinary excretion is not an important mechanism for the loss of glycyl-leucine or glycylglycine from plasma ( Table 1) . Blood lacks peptide hydrolase activity against glycylglycine, and its hydrolytic activity against glycyl-leucine could account for only a small fraction of the plasma disappearance of this dipeptide . Therefore the rapid clearance of glycylglycine and glycyl-leucine from plasma appears to be largely a reflection of transport (mechanism c) or hydrolysis (mechanism d) by tissues.
Rapid hydrolysis by intracellular enzymes probably has accounted for the lack of detection of glycylglycine and glycyl-leucine in the tissues of control rats (mechanism c). Indeed, dipeptide appeared in tissues when glycylsarcosine, which is resistant to hydrolysis, was used. Similarly, Nutzenadel & Scriver (1976) have independently concluded from their study that there is uptake of dipeptides by body tissues. By studies in vitro they have shown that slices of kidney cortex, intact hemi-diaphragm and scraped mucosal epithelium of jejunum all transport carnosine (/Ialanyl-L-histidine) in unhydrolysed form to the cell interior. The dipeptide transport by brain slices (Abraham, Pisano & Udenfriend, 1964; Yamaguchi, Yamaguchi & Lajtha, 1970) and by cultured fibroblasts (Grahl-Nielsen, Bdegaard & Tritsch, 1974) have also been reported by several independent laboratories.
Investigations of subcellular distribution of peptide hydrolase activity in the mucosal cells of the small intestine have revealed that the bulk of activity (80-95%) resides in the cell cytoplasm (Kim, Birtwhistle & Kim, 1972; Peters, 1970) .
Although studies of subcellular distribution of peptide hydrolase activity in extra-intestinal tissues are few as yet, plasma membranes of various organs of the rat appear to contain enzyme activity against some dipeptides (Kim et al., 1972) .
A parallel relationship between the order of rapidity of disappearance from plasma (Gly-Leu > Gly-Gly > Gly-Sar) and the order of peptide hydrolase activity (Gly-Leu > Gly-Gly > GlySar) suggests that hydrolysis plays an important role in the disappearance of these dipeptides from plasma. Although the present data do not allow a firm conclusion regarding the quantitative importance of superficial (mechanism d) versus intracellular (mechanism c) hydrolysis of glycylglycine and glycyl-leucine, they indicate that the hydrolysis of glycylsarcosine is probably intracellular. After glycylsarcosine injection, no sarcosine was detected in the plasma (absence of evidence for mechanism d for this dipeptide) and there was appearance of sarcosine in both the renal cortex and the intestinal mucosal cells (Fig. 10) .
Metabolic considerations
Among the various tissues in the body, the skeletal muscle and the liver utilize the greatest bulk of exogenous amino acids for protein synthesis, metabolic conversions or oxidative energy metabolism. The role of skeletal muscle (gastrocnemius) as an adaptive organ in amino acid transport and metabolism has recently become more evident (Adibi, Krzysik, Morse, Amin & Allen, 1974; Adibi et al., 1976; . In post-absorptive states, the plasma composition of amino acids is principally governed by the amino acid pool in the muscle and, to a lesser extent, by that of liver (Adibi, 1971a; Adibi, Modesto, Morse & Amin, 1973) . Therefore the enrichment of amino acid pools by dipeptides is metabolically more important in the muscle and the liver than in the kidney or the intestine. Under the conditions of the present experiments, enrichment of muscle and liver pools of glycine and leucine after glycyl-leucine injection or glycine pools after glycylglycine administration were similar to those occurring after the injection of the corresponding amino acid mixtures.
The metabolic effects of amino acid and dipeptide injections, such as changes in the concentrations of endogenous amino acids in tissues and plasma and enhanced glucagon secretion, were similar. However, glycyl-leucine appeared to exert a greater influence on insulin secretion than the corresponding free amino acid mixture. Since insulin stimulates protein synthesis (Manchester, 1970) and inhibits protein degradation (Mortimore & Mondon, 1970) , increased insulin secretion may have a physiological advantage.
Although a principal purpose of the present experiments was to compare, under identical experimental conditions, the metabolic effects of intravenous administration of dipeptides with those of free amino acids, this report also includes information on the metabolic responses to the experimental procedure. The studies in non-injected and saline-injected rats were made to determine which effects of amino acid and dipeptide injections could be attributed to the introduction of these substrates into the systemic circulation, and which effects were due to the experimental procedure. The results show that the injection was responsible for hyperglycaemia and, partially, for the lowered amino acid concentrations in tissues and plasma, but was not responsible for increased plasma insulin and glucagon (Fig. 7) .
Finally, the present study relates to the metabolic fate of circulating dipeptides after a bolus injection. The utilization of dipeptides under conditions of continuous infusion, which may have more clinical and nutritional relevance than a bolus injection, remains to be investigated. Nevertheless, in contrast to the report by Long, Zikria, Kinney & Geiger (1974) , which concluded that small peptides when infused intravenously are not efficiently utilized, the results of the present experiments encourage additional metabolic and clinical studies on the use of dipeptides as substrates for parenteral nutrition.
